Latin America is a focus for healthcare markets. During 2000-2010 the
region went through its highest economic growth period in the last four
decades. Economics brought almost a third of the total population in the
region into the middle class status with around 70 percent of them
living in Brazil, Mexico and Argentina. The economic development has
translated into investment in these nation's healthcare systems, which
in terms has increased the focus on high-end biotechnology instrument
spending for clinical research and diagnostics.

Genomics studies product cycle with Next Generation Sequencing (NGS)
technology in Latin America (LatAm) is in its exponential phase and
market growth is larger than the regional investment in Science and
Technology (S&T) compared against the expenditure in S&T as a percentage
of GDP. Because of that is necessary to know more details about the
market dynamics, products/applications segmentation and main purchase
drivers.

As part of its coverage, this report contains the following data:

Number of Next Generation Sequencing Systems Installed by Country

Brazil

Mexico

Argentina

Chile

Columbia

Others

Brands of Next Generation Sequencing Systems Installed In Latin
America, Cross-Referenced By Country

Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.